Literature DB >> 3592751

Antagonistic effect of ketanserin on vasoconstrictor responses to serotonin in isolated canine skin artery.

T Ito, S Chiba.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3592751     DOI: 10.1007/bf00413262

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


× No keyword cloud information.
  9 in total

1.  Vascular responsiveness of simian digital artery to various vasoactive substances.

Authors:  T Ito; S Chiba
Journal:  J Invest Dermatol       Date:  1986-06       Impact factor: 8.551

2.  Mechanism of the hypotensive effect of ketanserin.

Authors:  J R Fozard
Journal:  J Cardiovasc Pharmacol       Date:  1982 Sep-Oct       Impact factor: 3.105

3.  Hypersensitivity of scleroderma cutaneous vascular smooth muscle to 5-hydroxytryptamine.

Authors:  R K Winkelmann; M E Goldyne; R L Linscheid
Journal:  Br J Dermatol       Date:  1976-07       Impact factor: 9.302

4.  Existence of two types of postjunctional alpha adrenoceptors in the isolated canine intermediate auricular artery.

Authors:  T Ito; S Chiba
Journal:  J Pharmacol Exp Ther       Date:  1985-09       Impact factor: 4.030

Review 5.  Serotonin and Raynaud's phenomenon.

Authors:  J R Seibold
Journal:  J Cardiovasc Pharmacol       Date:  1985       Impact factor: 3.105

6.  The effects of platelet-derived contractile agents on human digital arteries.

Authors:  R F Moulds; V Iwanov; R L Medcalf
Journal:  Clin Sci (Lond)       Date:  1984-04       Impact factor: 6.124

7.  Treatment of Raynaud's phenomenon with ketanserin, a selective antagonist of the serotonin2 (5-HT2) receptor.

Authors:  J R Seibold; A H Jageneau
Journal:  Arthritis Rheum       Date:  1984-02

Review 8.  Serotonin and vascular reactivity.

Authors:  J M Van Nueten; W J Janssens; P M Vanhoutte
Journal:  Pharmacol Res Commun       Date:  1985-07

9.  Responses of isolated canine intermediate auricular arteries to 5-hydroxytryptamine and methysergide.

Authors:  T Ito; S Chiba
Journal:  Eur J Pharmacol       Date:  1984-09-03       Impact factor: 4.432

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.